445 results
424B5
LCTX
Lineage Cell Therapeutics Inc
14 May 24
Prospectus supplement for primary offering
4:36pm
made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties … from this offering to be used for any particular purpose, our management will have broad discretion as to the application of the net proceeds from
424B5
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Prospectus supplement for primary offering
4:32pm
for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements … this offering to be used for any particular purpose, our management will have broad discretion as to the application of the net proceeds from
8-K
EX-1.1
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
of the Registration Statement, or threatening or instituting proceedings for that purpose. The Registration Statement and the offer and sale of Placement Shares … unconsolidated entity, including, but not limited to, any structural finance, special purpose or limited purpose entity (each, an “Off-Balance Sheet
424B5
8753fj5kc8s xza
6 Feb 24
Prospectus supplement for primary offering
9:25am
8-K
EX-10.1
gd39 s9unrjzg9y
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
S-8
u28vgga7rkuqh tcim
13 Nov 23
Registration of securities for employees
4:19pm
S-8
mg3gt1c 224a
13 Nov 23
Registration of securities for employees
4:19pm
S-8
EX-5.1
7ok8h8 7jd6
13 Nov 23
Registration of securities for employees
4:19pm